FDA Drug Application (022152) for STAVZOR by BIONPHARMA INC

Back to FDA Applications sponsored by BIONPHARMA INC

Application Number022152
Product Number001
FormCAPSULE, DELAYED RELEASE;ORAL
Dosage125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSTAVZOR
Active IngredientVALPROIC ACID

Active IngredientCount
List of drugs with Active Ingredient VALPROIC ACID3


Back to FDA Applications sponsored by BIONPHARMA INC